Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Clinical Trials
Return to: PBR Home | Contract Research & Services | Clinical Trials | News
Search Refinements

Clinical Trials News

View news from other Pharmaceutical sectors:
1-15 of 4106 results
Incyte launches phase 3 trial of Itacitinib for acute graft-versus-host disease
Incyte reported that the first patient has been treated in a phase 3 trial dubbed GRAVITAS-301 for the first-line treatment of patients with acute graft-versus-host disease (GVHD).
Contract Research & Services > Clinical Trials > News
Tiziana launches phase IIa trial of milciclib in HCC patients
Tiziana Life Sciences has started enrolling of patients in its phase IIa clinical trial with cyclin-dependent kinases (CDKs) inhibitor milciclib in patients with refractory hepatocellular carcinoma (HCC).
Contract Research & Services > Clinical Trials > News
Vertex reports positive data from cystic fibrosis trials
Vertex Pharmaceuticals has reported positive data from Phase 1 and Phase 2 trials of three different triple combination regimens in cystic fibrosis (CF) patients who have one F508del mutation and one minimal function mutation (F508del/Min).
Contract Research & Services > Clinical Trials > News
PureTech Health presents inflammation drug research data at Boston Conference
PureTech Health has presented data for product candidate ALV-107 showing durable pain control throughout a 24-hour study period, lasting at least 12 times longer than lidocaine at a comparable dose (ALV-107 16 mg/kg, conventional lidocaine 16 mg/kg), in a validated preclinical model for the treatment of interstitial cystitis/bladder pain syndrome (IC/BPS).
Contract Research & Services > Clinical Trials > News
Amgen’s Kyprolis regimen improves survival rate phase 3 myeloma trial
By PBR Staff Writer
Amgen has reported that Kyprolis (Carfilzomib) in combination with lenalidomide and dexamethasone significantly improved the overall survival in a phase 3 trial in multiple myeloma patients whose disease had relapsed.
Contract Research & Services > Clinical Trials > News
Amicus plans to submit NDA to FDA for migalastat for fabry disease
Amicus Therapeutics has revealed its plans to file a new drug application (NDA) with the US FDA for the oral precision medicine migalastat for Fabry disease in the fourth quarter of the year.
Contract Research & Services > Clinical Trials > News
Elite reports topline results from bioequivalence fed study for SequestOx
Elite Pharmaceuticals has reported topline results from a pivotal bioequivalence fed study for SequestOx.
Contract Research & Services > Clinical Trials > News
Alnylam, Sanofi begin clinical trial program of hemophilia treatment fitusiran
By PBR Staff Writer
Alnylam Pharmaceuticals and Sanofi Genzyme have commenced Atlas Phase 3 clinical program for hemophilia treatment, fitusiran.
Contract Research & Services > Clinical Trials > News
Entasis, GARP to start phase 3 trials of drug-resistant gonorrhea antibiotic
By PBR Staff Writer
Entasis Therapeutics and Global Antibiotic Research and Development Partnership (GARDP) will initiate pivotal trials of oral antibiotic zoliflodacin (ETX0914) being developed to treat drug-resistant gonorrhea.
Contract Research & Services > Clinical Trials > News
Prothena commences phase 2 trial of Parkinson's disease drug
Prothena has reported that the first patient has been enrolled in PASADENA, a global Phase 2 study of PRX002/RG7935 in patients with early Parkinson's disease.
Contract Research & Services > Clinical Trials > News
Auris Medical completes patient enrollment for phase 3 trial of Am-111 to treat sudden deafness
Auris Medical has completed patient enrollment in the Phase 3 HEALOS clinical trial of AM-111 in idiopathic sudden sensorineural hearing loss (ISSNHL), also known as sudden deafness.
Contract Research & Services > Clinical Trials > News
FDA puts clinical hold on Merck’s three blood cancer trials
By PBR Staff Writer
The US Food and Drug Administration (FDA) has placed a clinical hold on three combination studies of Merck’s Keytruda (pembrolizumab) for the treatment of blood cancer.
Contract Research & Services > Clinical Trials > News
Zealand Pharma starts phase 3 trial of dasiglucagon to treat severe hypoglycemia in diabetes
Zealand Pharma has started a multinational Phase 3 clinical trial of dasiglucagon in four countries (Austria, Germany, Canada and the US).
Contract Research & Services > Clinical Trials > News
Daiichi Sankyo’ pain drug mirogabalin meets primary end point in Neucourse phase 3 study
By PBR Staff Writer
Daiichi Sankyo's pain drug mirogabalin has showed mixed results in phase 3 global clinical development program.
Contract Research & Services > Clinical Trials > News
Chi-Med, AstraZeneca start phase III trial of savolitinib in papillary renal cell carcinoma
By PBR Staff Writer
Chi-Med and AstraZeneca have commenced a phase 3 study of their c-MET receptor tyrosine kinase inhibitor savolitinib for the treatment of papillary renal cell carcinoma (PRCC).
Contract Research & Services > Clinical Trials > News
1-15 of 4106 results